Dr. Stefano Zanotti, PhDSVP, Head of Neuromuscular Research at Dyne TherapeuticsSpeaker
Profile
Stefano Zanotti, Ph.D. heads the Genetic Medicines Research department at Dyne Therapeutics, where he oversees a multidisciplinary research team dedicated to advancing Dyne pipeline by discovering and developing treatments for genetic disorders. Stefano has committed his scientific career to genetic disorders; prior to joining Dyne, he was Director of Rare Renal and Musculoskeletal Diseases at Sanofi. Prior to Sanofi, Stefano was Assistant Professor at the University of Connecticut School of Medicine, where he conducted NIH-funded research focused on genetic disorders of the skeletal system. Stefano has published numerous reviews, book chapters, and more than 50 research articles in major scientific journals; he is also an inventor on several patents in the field of oligonucleotide design and targeted drug delivery.
Agenda Sessions
Unlocking the Therapeutic Potential of Oligonucleotides for CNS Disorders Through Targeted Delivery
, 11:15amView Session
